Retrospective Chart Review of Children With Type 2 Diabetes Mellitus Evaluating the Efficacy of Metformin vs. Insulin vs. Combination Insulin/Metformin

2011 ◽  
Vol 104 (10) ◽  
pp. 684-688 ◽  
Author(s):  
Stacy L. Meyer ◽  
Robert P. Hoffman
2020 ◽  
Vol 6 (2) ◽  
Author(s):  
Al-Sharafi BA ◽  
Algoby MA ◽  
Salem K

Background and Aims: The war in Yemen caused the already weak health system in the country to decline. We conducted a 3-year retrospective chart review on patients with type 2 Diabetes Mellitus (DM) attending an endocrinology center for the first time during the war, most of the patients were treated by internists and in government hospitals prior to presentation and only a small amount had seen a specialist prior to presentation.


BMJ Open ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. e039258
Author(s):  
Salome Tino ◽  
Billy N Mayanja ◽  
Michael Charles Mubiru ◽  
Emmanuel Eling ◽  
Edward Ddumba ◽  
...  

ObjectivesTo assess the prevalence and risk factors of overweight and obesity among type 2 diabetes mellitus (T2DM) patients in Uganda.DesignRetrospective chart review.SettingThis study was conducted in the outpatient’s T2DM clinic in St. Francis Hospital—Nsambya, Uganda between March and May 2017.ParticipantsType 2 diabetes patients registered in the diabetes clinic between July 2003 and September 2016.Outcome measuresOverweight and obesity defined as body mass index (kg/m2) of 25.0–29.9 and obesity as 30.0 or higher.ResultsOf 1275 T2DM patients, the median age was 54 (IQR: 44–65) years, 770 (60.40%) were females, 887 (69.6%) had hypertension, 385 (28%) had controlled glycaemia, 349 (27%) were obese, while 455 (36%) were overweight. Overweight/obesity were lower among men (OR: 0.45, 95% CI: 0.340 to 0.593, p≤0.001) and among patients aged ≥65 years (OR: 0.52, 95% CI: 0.350 to 0.770, p=0.001); patients who rarely ate fruits and vegetables (OR: 0.66, 95% CI: 0.475 to 0.921, p=0.014) but higher among patients of middle (OR: 1.83, 95% CI: 1.320 to 2.550, p≤0.001) and upper (OR: 2.10, 95% CI: 1.450 to 2.990, p≤0.001) socioeconomic status; on dual therapy (OR: 2.17, 95% CI: 1.024 to 4.604, p=0.043); with peripheral neuropathy (OR: 1.40, 95% CI: 1.039 to 1.834, p=0.026) and hypertension (OR: 1.70, 95% CI: 1.264 to 2.293, p≤0.001).ConclusionsOverweight and obesity are high among T2DM patients in this population and may contribute significantly to poor outcomes of T2DM. Therefore, strategies to address this problem are urgently needed.


2016 ◽  
Vol 6 (2) ◽  
pp. 35-41
Author(s):  
Suhaib A. Radi ◽  
Nada K. Bashnini ◽  
Hebah Y. Alahwal ◽  
Deemah A. Tashkandi ◽  
Maram J. Sibyani ◽  
...  

Background: Diabetes mellitus is one of the most prevalent chronic diseases worldwide and is very debilitating. Studies have shown that adherence to treatment recommendations are rewarded with a decrease in diabetes mellitus - related morbidity and mortality. The aim of this study is to assess adherence to the American Diabetes Association treatment goals in patients with type 2 diabetes mellitus. Methods: This was a retrospective chart review study, between February and April, 2013, of patients with type 2 diabetes mellitus who attended outpatient clinics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. We included patients provided they were adults (≥ 18 years) with type 2 diabetes mellitus who were regularly followed up at the outpatient clinics, and they have had the disease for more than one year. Results: We included 201 patients between 27 – 96 years old. Most patients had their blood pressure and creatinine levels measured during each visit, and close to half had their HbA1c levels measured twice in the last year of follow up. Approximately 55.10% of the patients achieved an LDL level < 2.6 mmol/L. A relatively small proportion of the patients had blood pressure measurements and HbA1c levels within the recommended guidelines (29.03% and 24.53%, respectively). Conclusion: Diabetes mellitus is not very well controlled. This could be attributed to physicians’ factors and patients’ factors. Further studies to assess this issue are recommended.  


2021 ◽  
Author(s):  
Tigist Workneh Leulseged

Abstract Background Diabetes is a chronic illness that requires continuous medical care to reach target glycaemic level to prevent complications. Most studies around the world have showed that glycaemic control among type 2 diabetes mellitus (T2DM) patients is poor using measurements taken at one point and including all patients irrespective of the duration of illness. This study aimed to assess achievement of optimal glycaemic control at different points in time in relation to the time of diagnosis and initiation of treatment and to identify associated factors among T2DM patients attending diabetes clinic of public teaching hospitals in Addis Ababa, Ethiopia. Methods A retrospective chart review was conducted from May to July 2018 among randomly selected 685 medical charts of patients who were on follow-up from January, 2013 to December, 2017. Association was assessed using Binary logistic regression, where 95% CIs for odds ratio and P-values were used for testing significance and interpretation of results. Results The prevalence of optimal glycaemic control among T2DM patients at the end of 3 months, 6 months, 1 year, 2 years, 3 years, 4 years and 5 years of diagnosis and treatment were 1.9%, 44.7%, 52.8%, 66.3%, 69.2%, 70.2% and 70.5% respectively. The significant factors were age group and type of treatment regimen. Conclusions Achievement of optimal glycaemic control increases as the follow-up duration increases; it was only 1.9% at the third month and 70.5% at the fifth year of observation. Close to one third of patients (29.5%) did not achieve target glucose even after five years and were at the verge of increased risk for diabetes related complications and death. Attention should be given to the time when patients achieve target glucoses level instead of just measuring the number of individuals who achieved glycaemic control in a short observation period.


2017 ◽  
Vol 59 (3) ◽  
pp. 38
Author(s):  
Romona Devi Govender ◽  
Prem Gathiram ◽  
Miljenko Panajatovic

Evidence shows that even with the implementation of evidence-based medicine, the attainment of optimal glycaemic control is difficult and challenging for both patients and healthcare providers. This study was a one-year retrospective chart review with data collected during the period October 2010 to December 2010 of patients with Type 2 diabetes mellitus (T2DM) who attended the outpatients’ department at the Port Shepstone Regional Hospital (PSRH), South Africa (SA). The total study population was 360 patients with 51% Black African, 32% Indian, 16% White and 1% Coloured. Of the 111 patients’ charts only 78 had two consecutive HbA1c levels recorded. Of the 78/111 patients, only 10 patients had the target HbA1c level of < 7% at visit 1. By visit two, 15.4% (n = 12) had achieved the target HbA1c level. Over the one-year chart review only 3/111 (2.7%) maintained their HbA1c level of < 7% and 5/111 patients whose treatment was revised according to the 2009 SEMDSA guidelines reached HbA1c < 7% by visit 2 whilst 4/111 patients, whose treatment schedule was not modified according to the 2009 SEMDSA guidelines, also reached HbA1c < 7% at visit 2. However, this one-year chart review showed that glycaemia was poorly managed at this hospital, which may be explained by clinical inertia. (Full text of the research articles are available online at www.medpharm.tandfonline.com/ojfp) S Afr Fam Pract 2017; DOI: 10.1080/20786190.2017.1307909


Sign in / Sign up

Export Citation Format

Share Document